L. S. Hoff Et Al. , "COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.," Rheumatology international , vol.43, no.1, pp.47-58, 2023
Hoff, L. S. Et Al. 2023. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.. Rheumatology international , vol.43, no.1 , 47-58.
Hoff, L. S., Ravichandran, N., Shinjo, S. K., Day, J., Sen, P., Junior, J. G., ... Lilleker, J. B.(2023). COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.. Rheumatology international , vol.43, no.1, 47-58.
Hoff, Leonardo Et Al. "COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.," Rheumatology international , vol.43, no.1, 47-58, 2023
Hoff, Leonardo S. Et Al. "COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.." Rheumatology international , vol.43, no.1, pp.47-58, 2023
Hoff, L. S. Et Al. (2023) . "COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.." Rheumatology international , vol.43, no.1, pp.47-58.
@article{article, author={Leonardo Santos Hoff Et Al. }, title={COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.}, journal={Rheumatology international}, year=2023, pages={47-58} }